Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Sysmex ( (JP:6869) ).
Sysmex Corporation announced its decision to absorb its wholly owned subsidiary, Sysmex Medica Co., Ltd., to streamline its equipment production process and enhance efficiency. The merger, set to be effective from April 1, 2026, will be conducted as an absorption-type merger, with Sysmex Corporation as the surviving entity, and is expected to improve productivity without the issuance of new shares or monetary allotments.
The most recent analyst rating on (JP:6869) stock is a Buy with a Yen2400.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.
More about Sysmex
Sysmex Corporation operates in the healthcare industry, focusing on the development, manufacture, sales, and export/import of diagnostic instruments, reagents, and related software. The company is known for its comprehensive solutions in diagnostics and aims to optimize production processes within its group companies.
Average Trading Volume: 3,057,703
Technical Sentiment Signal: Sell
Current Market Cap: Yen936.7B
Learn more about 6869 stock on TipRanks’ Stock Analysis page.